INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sarepta Therapeutics
If you suffered losses exceeding $100,000 in Sarepta between June 22, 2023 and June 24, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
New York, New York--(Newsfile Corp. - August 11, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Sarepta Therapeutics, Inc. ('Sarepta' or the 'Company') (NASDAQ: SRPT) and reminds investors of the August 25, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
[ This image cannot be displayed. Please visit the source: https://images.newsfilecorp.com/files/6455/262020_7c741e2d64a178ce_001.jpg ]
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (i) ELEVIDYS posed significant safety risks to patients; (ii) ELEVIDYS trial regimes and protocols failed to detect severe side effects; (iii) the severity of adverse events from ELEVIDYS treatment would cause the Company to halt recruitment and dosing in ELEVIDYS trials, attract regulatory scrutiny, and create greater risk around the therapy's present and expanded approvals; and (iv) as a result of the foregoing, Defendants materially misled with, and/or lacked a reasonable basis for, their positive statements.
On March 18, 2025, Sarepta issued a safety update on ELEVIDYS announcing that a patient had died following treatment with ELEVIDYS.
On this news, Sarepta's stock price fell $27.81 per share, or 27.44%, to close at $73.54 per share on March 18, 2025.
Then, on April 4, 2025, Sarepta disclosed that European Union member country authorities had requested that the independent data monitoring committee meet to review death announced on March 18, 2025. Sarepta simultaneously halted recruitment and dosing in some of the ELEVIDYS clinical studies.
On this news, Sarepta's stock price fell $4.18 per share, or 7.13%, to close at $54.43 per share on April 4, 2025.
Next, on June 15, 2025, Sarepta disclosed a second patient had died of acute liver failure following treatment with ELEVIDYS. The Company announced it was suspending shipments of ELEVIDYS for non-ambulatory patients while Sarepta took time to evaluate trial regimens and discussed findings with regulatory authorities. Sarepta also revealed that it was pausing dosing in one of its ELEVIDYS clinical studies.
On this news, Sarepta's stock price fell $15.24 per share, or 42.12%, to close at $20.91 per share on June 15, 2025.
Finally, on June 24, 2025, the United States Food and Drug Administration ('FDA') issued a Safety Communication announcing it had received reports of two deaths and was investigating the risk of acute liver failure with serious outcomes following treatment with ELEVIDYS. The communication noted that the FDA was evaluating the need for further regulatory action.
On this news, Sarepta's stock price fell $1.52 per share, or 8.01%, to close at $17.46 per share on June 25, 2025.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Sarepta's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the Sarepta Therapeutics class action, go to www.faruqilaw.com/SRPT or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com ). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/262020
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
Americas Gold And Silver Corp (USAS) Q2 2025 Earnings Call Highlights: Silver Production Soars ...
Release Date: August 11, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Americas Gold And Silver Corp (USAS) significantly strengthened its balance sheet by closing a $100 million senior secured debt facility with SAF, providing capital for growth, particularly at the Galena complex. The company achieved a 54% increase in silver production in Q2 2025, producing 689,000 ounces, reflecting strong operational performance. A new 5-year offtake agreement for 100% of Galena's production was secured, providing revenue certainty and improved terms for byproduct credits. The introduction of long hole scoping at Galena has led to higher productivity rates and lower costs, marking a significant operational improvement. The company reported a cash balance increase to $62 million, up by $53 million from Q1, mainly due to the first tranche of the term loan facility and offtake financing. Negative Points Revenue decreased to $27 million in Q2 2025 from $33 million in Q2 2024, attributed to lower zinc and lead production. The company reported a net loss of $15 million, an increase from $4 million in Q2 2024, driven by investments in revitalizing the Galena mine and transitioning to EC 120 at Cosala. Cost of sales per silver equivalent ounce was approximately $28, with cash costs at $26.64 per silver ounce and all-in sustaining costs at $32.89 per silver ounce. The adjusted EBITDA was a $4 million loss, indicating ongoing financial challenges despite operational improvements. The transition to EC 120 at Cosala led to a dip in base metal output, impacting overall revenue despite increased silver production. Q & A Highlights Warning! GuruFocus has detected 9 Warning Signs with USAS. Q: Can you elaborate on the financial impact of the new $100 million senior secured debt facility? A: Paul Hewitt, CEO, explained that the $100 million debt facility with SAF Group significantly strengthens the company's balance sheet. It provides the necessary capital to fuel their growth strategy, particularly at the Galena complex, enabling increased development rates, boosted mining tonnages, and reduced unit costs. Q: What are the expected benefits of the new long hole stoping method at Galena? A: Paul Hewitt, CEO, highlighted that the long hole stoping method offers safety improvements, higher productivity rates, lower costs, increased backfill capacity, and reduced waste. This method allows for drilling and blasting up to 7,000 tons compared to the previous 50-70 tons, marking a significant operational shift. Q: How did the production numbers for Q2 2025 compare to previous quarters? A: Paul Hewitt, CEO, reported a 54% increase in silver production, reaching 689,000 ounces compared to 446,000 ounces in Q1. Galena saw a 34% increase, producing 420,000 ounces, while Cosala in Mexico achieved a 103% increase, contributing 269,000 ounces. Q: What are the financial highlights for Q2 2025? A: Warren Varga, CFO, stated that revenue was $27 million, down from $33 million in Q2 2024 due to lower zinc and lead production. The net loss was $15 million, driven by investments in Galena and the transition to EC 120 at Cosala. However, the cash balance increased to $62 million, supported by the debt facility and offtake financing. Q: What strategic developments are enhancing the company's market visibility? A: Oliver Turner, EVP of Corporate Development, mentioned hosting an analyst tour at Galena and achieving 82% of revenue from silver, surpassing their short-term goal. The upcoming share consolidation aims to expand the stock's investability, potentially enhancing liquidity and attracting larger institutional investors. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
27 minutes ago
- Yahoo
GreenFirst Forest Products Inc (ICLTF) Q2 2025 Earnings Call Highlights: Record Production ...
Release Date: August 13, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points GreenFirst Forest Products Inc (ICLTF) achieved the highest production in company history with 1,160 million board feet, significantly reducing manufacturing costs. The company reported a strong sales volume of 110 million board feet, despite market uncertainties. GreenFirst Forest Products Inc (ICLTF) is actively working with the federal government on a $1.2 billion industry support plan, which could benefit the company. The company is implementing strategic capital projects, including a new saw line and cogeneration plant, expected to improve cost structure and profitability. GreenFirst Forest Products Inc (ICLTF) recorded a significant safety improvement, reducing the recordable incident rate by 50% compared to 2024. Negative Points GreenFirst Forest Products Inc (ICLTF) reported a net loss of $9.6 million in Q2 2025, with an adjusted EBITDA of negative $5.2 million. The company faced higher costs of sales due to inventory adjustments and increased SG&A expenses. Market uncertainty, including increased tariffs and duties, negatively impacted demand and pricing. The company is subject to a higher duty rate of 35.19% for Canadian shipments to the US, which could increase costs. Despite production records, the financial benefits have not yet been realized due to timing differences in cost of sales. Q & A Highlights Warning! GuruFocus has detected 2 Warning Sign with ICLTF. Q: What are the company's thoughts on the recent announced duty increase from 14.4% to 35.19% for Canadian shipments to the US, and what will be the impact on the business? A: Michel Lassard, President: The increased duty rate is concerning, but historically, most of these costs have been passed on to the end consumer, increasing housing costs in the US. We are exploring different market opportunities and hope for a resolution soon, as the Canadian industry has already paid $7.5 billion in duties since 2017. Q: Can you talk about current demand and pricing trends? A: Joel Fournier, CEO: Prices decreased in Q2, but recent duty rate announcements have led to an increase in lumber futures. Despite uncertainties, we shipped 110 million board feet, driven by strong relationships with home centers. Competitor mill curtailments may reduce supply and pressure prices upward. Q: Why don't we see the benefits of record production in the financial statements? A: Peter Ferrante, CFO: The majority of lumber sold in Q2 was produced in the prior quarter, so those production costs are reflected in Q2's cost of sales. We expect the benefits of Q2 production to reduce costs in Q3 as we sell that inventory. Q: Can you provide an update on the CapEx related to the Shale large log line project? A: Joel Fournier, CEO: We are installing a new large log line, planar mill, and cogeneration plant at the Shale sawmill. This will significantly improve profitability and cost efficiency, replacing a 40-year-old line with new technology, including AI. Q: Why is GreenFirst subject to a higher 34% duty compared to 22% for smaller players? A: Michel Lassard, President: The duty rate is an average calculated from selected major lumber producers. GreenFirst, like other companies, receives this average rate. Q: What is the company's plan if Section 232 tariffs are imposed? A: Joel Fournier, CEO: We have prepared scenarios for potential tariffs and paused half of our $50 million CapEx to maintain a strong balance sheet. We are also exploring international markets and local partnerships to diversify sales. Q: How would a quota system impact GreenFirst's operations? A: Joel Fournier, CEO: A quota could impact us, but we are preparing by developing partnerships with local consumers in Toronto to diversify sales. We aim to reduce reliance on the US market. Q: Will GreenFirst benefit from the Canadian government's $1.2 billion support program? A: Michel Lassard, President: We are pleased with the government's focus on the lumber industry and are in discussions to understand how we can benefit. We are ready to utilize available funds for projects once details are provided. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Sign in to access your portfolio
Yahoo
27 minutes ago
- Yahoo
Intellinetics Inc (INLX) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic ...
Release Date: August 13, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Intellinetics Inc (INLX) successfully renewed a five-year contract with its largest customer, with an additional five-year extension option. The company has rebuilt its backlog with orders that will restore transformation work to historical levels by the end of Q3. Intellinetics Inc (INLX) completed successful testing on a large microfilm conversion project, expected to add revenue in Q4 and beyond. The company has grown revenues at 12.6% in Q2 year-over-year, despite challenges in key vertical markets. Intellinetics Inc (INLX) has paid off $7.6 million in debt and earnouts, positioning itself to invest in sales, marketing, and development for future growth. Negative Points Total revenue for Q2 2025 decreased by 13.6% compared to the same period last year, primarily due to a reduction in professional services revenue. Operating expenses increased by 21.1% in Q2 2025, driven by investments in sales, marketing, and infrastructure. The company reported a net loss of $568,000 for Q2 2025, compared to a net income of $75,000 in the same period last year. Intellinetics Inc (INLX) expects 2025 revenues to be less than 2024 revenues due to weakness in professional services in the first half of the year. Adjusted EBITDA for Q2 2025 was significantly lower at $28,000 compared to $698,000 in the same period in 2024, due to reduced professional services and increased investment spending. Q & A Highlights Warning! GuruFocus has detected 3 Warning Signs with INLX. Q: In terms of the professional services ramping back up to historical levels, should we also model out that margins will be relatively healthy at historical levels or maybe even a little better than historical levels? A: Yes, we expect margins to be a little bit better than historical levels. The June 1 renewal, which includes a 5-year contract with an extension, comes with some price increases embedded, leading to anticipated margin improvement. (Respondent: CFO) Q: How many customers on the home builder side are live, and how many have paused but are expected to go live in the next 6 months? A: Currently, 80% of our customers are live, and the rest are moving aggressively towards live dates. The product has matured over the last year, and customers are satisfied, with many being referenceable. (Respondent: CEO) Q: From this point forward, should we expect double-digit growth in the fast line if nothing else out of the ordinary occurs? A: Yes, the pipeline is strong, and we haven't lost any business. We anticipate a strong fourth quarter, especially with the launch of our payables automation product into the K-12 market and other initiatives. (Respondent: CEO) Q: Has the pipeline for K-12 utilizing the IPA grown, and have more customers gone live? A: Yes, we now have four live customers in the K-12 market, up from three. We are also negotiating upsells and expanding our marketing efforts, expecting significant results in this sector. (Respondent: CEO) Q: Can you talk about any progress being made on entering new verticals or ERP verticals? A: We have a partner manager working diligently on this. We signed Spring Brook earlier in the year, and we are actively calling on new partners to expand our ecosystem. (Respondent: CEO) For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus.
